First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market
May 10, 2024 07:55 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Ocugen to Present at May 2024 Investor Conferences
May 10, 2024 07:45 ET
|
Ocugen
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Amesite Releases New Suite of AI Tools for Job Applications on NurseMagic™ App
May 10, 2024 07:30 ET
|
Amesite Inc.
DETROIT, May 10, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets,...
Inspired Reports First Quarter 2024 Results
May 10, 2024 07:05 ET
|
Inspired Entertainment, Inc.
This is an earnings release.
Antelope Enterprise Announces Second Half and Full Year 2023 Financial Results
May 10, 2024 07:00 ET
|
Antelope Enterprise Holdings Ltd.
NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a...
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
May 10, 2024 07:00 ET
|
Pacira BioSciences
TAMPA, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029...
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
May 10, 2024 07:00 ET
|
Century Therapeutics, Inc.
In vitro data showcases CNTY-101’s ability to induce CD19-specific cytolysis of B-cells and potential to treat B-cell driven autoimmune diseases including systemic lupus erythematosus (SLE)Preclinical...
Inspired Exclusively Launches Virtual Sports Betting Game, “NBA Re-Play”, With OPAP
May 10, 2024 07:00 ET
|
Inspired Entertainment, Inc.
NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, systems and solutions, today...
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 10, 2024 07:00 ET
|
Instil Bio
DALLAS, May 10, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its...
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
May 10, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...